Allied Biotech (ROCO:1780) Institutional Ownership: 0.00% (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1780 Allied Biotech Corp ROCO:1780
78 GF Score
Price NT$24.50
GF Value NT$22.10
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Allied Biotech Institutional Ownership?

Allied Biotech ROCO:1780 -1.41% 78 Institutional Ownership is 0.00% as of Aug. 31, 2026. GuruFocus rates ROCO:1780 with a GF Score™ of 78/100 and a GF Value™ of NT$22.10 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Allied Biotech's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Allied Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Allied Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Allied Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Allied Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Biotech Institutional Ownership Chart

Allied Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Institutional Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Allied Biotech Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Institutional Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:1780
78GF Score
Allied Biotech Corp ROCO:1780
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allied Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
Allied Biotech (ROCO:1780) has a Institutional Ownership of 0.00% as of Aug. 31, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Allied Biotech and its competitors.
Is Allied Biotech's Institutional Ownership too high?
Allied Biotech's current Institutional Ownership is 0.00%. Overall, Allied Biotech has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's Institutional Ownership compare to ZTS?
Allied Biotech's Institutional Ownership of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Allied Biotech and its competitors. Allied Biotech's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$22.10, compared to a current price of NT$24.50 — trading 10.9% above its estimated fair value. The current Institutional Ownership is 0.00%. Allied Biotech's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current Institutional Ownership is 0.00% as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allied Biotech (ROCO:1780) Overvalued in 2026?

Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued. The current stock price of NT$24.50 is trading 10.9% above its estimated GF Value™ of NT$22.10. GuruFocus considers Allied Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:1780:

  • Institutional Ownership: 0.00%
  • GF Value™: NT$22.10 vs. price of NT$24.50 (10.9% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allied Biotech Business Description

Address No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
78GF Score

Get the complete analysis for ROCO:1780

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.50
Price
NT$22.10
GF Value